Professional Documents
Culture Documents
NI DUNG
1. t vn
2. Mc tiu nghin cu
3. Tng quan ti liu
4. i tng Phng php nghin cu
5. Kt qu - Bn lun
6. Kt lun Kin ngh
T VN
T VN
S dng KS cha hp l
khng KS
T VN
Nghin cu ca Arno Muller
Ch c fluoroquinolone v cephalosporin: PDD ~ DDD.
64 KS c PDD khc DDD.
Cc nhm khc: PDD khc DDD.
MC TIU NGHIN CU
MC TIU NGHIN CU
Mc tiu tng qut
So snh PDD vi DDD nh gi SDKS ti BVND115
t 7/2015 6/2016.
Mc tiu c th
T thng 7/2015 thng 6/2016:
n v o lng c lp vi:
Gi, tin t, kch c ng gi, hm lng.
Cc bc tnh s DDD
Bc 1: Tnh tng lng thuc s dng
(hoc mua)/nm theo n v ti thiu
Bc 2: Tnh tng lng thuc tiu
th/nm theo n v mg/UI (g/UI) = s
lng x hm lng
Bc 3: s liu bc 2/ DDD ca thuc
kho st
Tng s DDD
Tng s ngy ging
x 1000
PDD c th c xc nh t NC k n.
PDD: lng thuc TB hng ngy thc s k n.
T s DDD/s ngy iu tr
Kt qu NC trn 15 BV
- Ngoi khoa:
I TNG - PPNC
I TNG - PPNC
Thit k nghin cu
M t, ct ngang, hi cu c phn tch.
Dn s chn mu
- NB ni tr s dng KS ti BVND115.
I TNG - PPNC
Tiu chun chn mu
- NB ni tr s dng KS ti BVND115.
I TNG - PPNC
C mu
Tt c NB ni tr SDKS ti BVND115.
T 01/07/2015 30/06/2016 theo cc TC trn.
Trong NC chn c 23.791 BN SDKS, 47 KS.
I TNG - PPNC
Phng php tin hnh
Tnh cc bin s sau
I TNG - PPNC
Thu thp s liu
KT QU - BN LUN
KT QU - BN LUN
T 7/2015 - 6/2016:
KT QU - BN LUN
KQ phn tch s DDD/1000 ngy ging ca tt c KS
Khi
S ngy ging
S DDD
DDD/1000
16.379
23.661
1.444,6
Khi ngoi
186.476
184.887
991,5
Khi ni
153.478
173.749
1.132,1
Tng
356.333
382.298
Hi sc tch cc
KT QU - BN LUN
So snh s DDD/1000 ngy ging ca NC:
BVND115 vi Arno Muller, Ion-Nedelcu N
3500
3000
2500
2000
1500
1000
500
0
Hi sc tch cc
Khi ngoi
Nghin cu BVND115
Khi ni
Arno Muller
Ion-Nedelcu N.
Tnh chung
160000
140000
120000
1.8
lactam khc
1.6
Quinolone
1.4
Macrolide,
lincosamidev
streptogramin
Khng sinh khc
1.2
100000
1
80000
Glycopeptide
0.8
Polymyxin B
60000
0.6
S DDD
40000
20000
S ngy KS
Aminoglycoside
0.4
Sulfonamidev
trimethoprim
0.2
Tetracycline
0
DDD/s ngy T
-2
-4
-6
amoxicillin and enzyme inhibitor
ceftriaxone
levofloxacin
cefuroxime
ciprofloxacin
meropenem
ampicillin and enzyme inhibitor
ceftazidime
cefoperazone
moxifloxacin
fosfomycin
levofloxacin
ertapenem
clarithromycin
vancomycin
ciprofloxacin
colistin
cefixime
cefuroxime
imipenem and enzyme inhibitor
amikacin
amoxicillin and enzyme inhibitor
clindamycin
cefoperazone, combinations
gentamicin
piperacillin and enzyme inhibitor
cefepime
amoxicillin
ticarcillin and enzyme inhibitor
cefazolin
ceftizoxime
sulfamethoxazole
clindamycin
cefaclor
doxycycline
cefpirome
azithromycin
linezolid
norfloxacin
cefpodoxime
tigecycline
cefalexin
azithromycin
oxacillin
cefdinir
erythromycin
cefadroxil
10
Liu k n <DDD
-8
-10
Chnh lch PDD -DDD
tim
1,04
levofloxacin
tim
1,2
cefuroxime
Ung
2,04
ciprofloxacin
tim
1,02
Khi ngoi
(P*)
2,1
Hi sc tch cc
(P1*,P2*)
1,9
(<0,000)
(0,2;0,7)
1,05
(0,4)
1,5
(0,000)
2,15
(0,1)
0,88
(0,000)
0,98
(0,001;0,000)
1,6
(0,000;0,000)
ND*
1,31
(0.000;0.000)
P*: Khi ngoi vs Khi ni; P1*: Hi sc tch cc vs Khi ni; P2*: hi sc tch cc vs Khi ngoi; ND*: khng tnh, s lng nh hn 30
Tn khng sinh
ng
Khi ni
dng
meropenem
tim
1,27
ampicillin v
enzyme inhibitor
Tim
1,3
ceftazidime
Tim
0,69
cefoperazone
tim
0,71
Khi ngoi
(P*)
1,27
(0,9)
1,1
(0,000)
0,53
(0,000)
0,50
(0,000)
Hi sc tch cc
(P1*,P2*)
1,27
(0,9;0,9)
2,87
(0,000;0,000)
1,07
(0,000;0,000)
0,81
(0,02;0,000)
P*: Khi ngoi vs Khi ni; P1*: Hi sc tch cc vs Khi ni; P2*: hi sc tch cc vs Khi ngoi; ND*: khng tnh, s lng nh hn 30
im hn ch ca nghin cu
Phn loi BN cc khi cha tht chnh xc.
BN qu ti ti khoa HSTCC, chuyn Khoa GMHS
D liu KS c tnh cho Khoa GMHS.
Hi sc tch cc (1.444,6);
Khi ni (1.132,1);
Khi ngoi (991,5).
SD theo khi:
S DDD vt qu s ngy TKS : 20%.
T sut: s DDD/s ngy TKS ch ra s khc nhau,
BVND115.
Ch s PDD phn nh tt hn thi gian s dng KS.
Ch s DDD tt so snh s dng KS:
Cc BV trong cng khu vc, cng quc gia.
So snh quc t.
CM N CC ANH/CH
CH LNG NGHE